Four years after British Columbia announced its Biosimilars Initiative and seven provinces and two territories followed suit, Arthritis Research Canada – the country's largest clinical arthritis research organization – is sharing its findings about how this policy change is affecting people living with arthritis.
VANCOUVER, BC, Sept. 1, 2023 /CNW/ - September is Arthritis Awareness Month, and Arthritis Research Canada is highlighting this invisible and often misunderstood disease by sharing the positive impact that vital
Mental health issues are a constant struggle for people with rheumatic diseases. A study by Arthritis Research Canada conducted during the peak of the COVID-19 pandemic has identified connections between social isolation and loneliness, and.
A real-world analysis of the impact of biosimilar switches over 3 years of follow-up addresses the limitations of formal trials in assessing discontinuation rates.